Deep Dive 209 – Who Should Decide Whether Drugs Are Available Over-The-Counter or by Prescription?
MP3•Źródło odcinka
Manage episode 320758407 series 3276400
Treść dostarczona przez The Federalist Society. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez The Federalist Society lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
In October 2020, Michael Cannon and Jeffrey Singer proposed ending the U.S. Food and Drug Administration's authority to decide which drugs are available only by prescription. Their solution: leaving the decision to the drugs' manufacturers. This Regulatory Transparency Project program featured Michael Cannon, former FDA official Joshua Sharfstein, and moderator Dan Troy discussing prescription drugs, nonprescription drugs, and who decides.
Featuring:
- Michael Cannon, Director of Health Policy Studies, Cato Institute
- Joshua Sharfstein, Vice Dean for Public Health Practice and Community Engagement, Bloomberg School of Public Health, Johns Hopkins University
- [Moderator] Dan Troy, Chief Business Officer, Chief Administrative Officer, and General Counsel, Valo
Visit our website – www.RegProject.org – to learn more, view all of our content, and connect with us on social media.
…
continue reading
Featuring:
- Michael Cannon, Director of Health Policy Studies, Cato Institute
- Joshua Sharfstein, Vice Dean for Public Health Practice and Community Engagement, Bloomberg School of Public Health, Johns Hopkins University
- [Moderator] Dan Troy, Chief Business Officer, Chief Administrative Officer, and General Counsel, Valo
Visit our website – www.RegProject.org – to learn more, view all of our content, and connect with us on social media.
373 odcinków